Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.

Lim KJC, Tan M, Parrondo R, Chhabra S, Dooley K, De Menezes Silva Corraes A, Carabenciov D, Gertz M, Hwa L, Haily S, Kapoor P, Kourelis T, Warsame R, Cook J, Binder M, Bergsagel PL, Yadav U, Wiedmeier-Nutor E, Geyer S, Ailawadhi S, Fonseca R, Kumar S, Zekeridou A, Lin Y.

Blood Cancer J · 2025-12-31

DOI: 10.1038/s41408-025-01441-3PMID: 41476076